Waystar Holding Corp (WAY) Q1 2026 Earnings Call Transcript

Why It Matters

The results validate Waystar’s hybrid growth model—organic expansion plus strategic acquisition—and signal that AI integration is becoming a core revenue engine, positioning the firm for sustained profitability and market leadership in healthcare revenue cycle management.

Key Takeaways

• Revenue up 24% YoY, $304M Q4.
• AI drives 40% of 2025 revenue, 30% new bookings.
• Iodine acquisition adds 1,000 hospitals, 90% synergies 2026.
• Net revenue retention 112%, gross retention 97%.
• Leverage down to 3x, cash $86M.

Pulse Analysis

Waystar’s latest earnings illustrate how a combined organic‑growth and acquisition strategy can accelerate scale in the fragmented health‑care technology market. The Iodine Software purchase not only expanded the client base by over a thousand hospitals but also unlocked cross‑sell opportunities that lifted subscription revenue by 38% year‑over‑year. By integrating Iodine’s clinical intelligence with Waystar’s financial data, the firm now offers a unified platform that captures both clinical and payment insights, a rare capability that strengthens its competitive moat.

Artificial intelligence is at the heart of Waystar’s value proposition, powering roughly 40% of its 2025 revenue and influencing nearly a third of new contracts. The company’s Altitude AI suite has prevented $15 billion in claim denials and cut appeal times by 90%, delivering tangible ROI for providers. Leveraging one of the nation’s largest health‑care payment datasets—over seven billion transactions annually—Waystar continuously refines its models, creating a virtuous cycle where each processed claim improves AI accuracy, further entrenching the platform in provider workflows.

Financially, Waystar entered 2026 with $86 million in cash, $1.5 billion of gross debt and net leverage around three‑times, reflecting disciplined deleveraging post‑acquisition. The guidance of $1.284 billion revenue and $535 million EBITDA, coupled with a projected 42% margin, exceeds long‑term expectations and signals confidence in sustained growth. Investors should watch the rollout of new AI‑driven products and the realization of $14‑$15 million in cost synergies, both of which could enhance cash flow and support further strategic acquisitions while maintaining leverage discipline.